Table 2.
Study | Selection (0-4) | Comparability(0-2) | Outcome (0-3) | Total | ||||||
---|---|---|---|---|---|---|---|---|---|---|
REC | SNEC | AE | DO | SC | AF | AO | FU | AFU | ||
Sotelo 2014 [24] | * | * | * | * | - | - | * | * | - | 6 |
Seeberg 2014 [25] | * | * | * | * | - | - | * | * | * | 7 |
Gazzaniga 2013 [26] | - | * | * | * | - | - | * | - | - | 4 |
Aggarwal 2013 [27] | - | * | * | * | - | - | * | * | - | 5 |
Kuboki 2013 [14] | - | * | * | * | - | - | * | * | - | 5 |
Deneve 2013 [13] | - | * | * | * | - | - | * | * | - | 5 |
Sastre 2012 [28] | * | * | * | * | - | - | * | * | - | 6 |
Sato 2012 [29] | * | * | * | * | - | - | * | - | - | 5 |
Papavasiliou 2010 [30] | - | - | * | * | - | - | * | - | - | 3 |
Tol 2010 [31] | * | * | * | * | - | - | * | - | - | 5 |
Hiraiwa 2008 [15] | - | * | * | * | - | - | * | - | - | 4 |
NOTE. REC: representativeness of the exposed cohort; SNEC: selection of the non-exposed cohort; AE: ascertainment of exposure; DO: demonstration that outcome of interest was not present at start of study; SC: study controls for age, sex; AF: study controls for any additional factors (chemoradiotherapy, curative resection); AO: assessment of outcome; FU: follow-up long enough (36M) for outcomes to occur; AFU: adequacy of follow-up of cohorts (≥90%).'*' means that the study is satisfied the item (high quality with no bias), and '-' means that the study is not satisfied the item (low quality with bias); Total: the number of high-quality items (no bias) in each study.